Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurosurgery. 2012 Mar;70(3):566-72; discussion 572-3. doi: 10.1227/NEU.0b013e3182320d36.

Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery.

Author information

1
Department of Radiation Oncology, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA.

Abstract

BACKGROUND:

Gamma Knife radiosurgery (GKRS) has been reported to be an effective modality to treat trigeminal neuralgia.

OBJECTIVE:

To determine predictive factors for the successful treatment of trigeminal neuralgia with GKRS.

METHODS:

Between 1999 and 2008, 777 GKRS procedures for patients with trigeminal neuralgia were performed at our institution. Evaluable follow-up data were obtained for 448 patients. Median follow-up time was 20.9 months (range, 3-86 months). The mean maximum prescribed dose was 88 Gy (range, 80-97 Gy). Dosimetric variables recorded included dorsal root entry zone dose, pons maximum dose, dose to the petrous dural ridge, and cisternal nerve length.

RESULTS:

By 3 months after GKRS, 86% of patients achieved Barrow Neurologic Institute I to III pain scores, with 43% of patients achieving a Barrow Neurologic Institute I pain score. Twenty-six percent of patients reported posttreatment facial numbness; 28% of patients reported a post-GKRS procedure for relapsed pain, and median time to next procedure was 4.4 years. Multivariate analysis revealed that the development of postsurgical numbness (odds ratio [OR], 2.76; P = .006) was the dominant factor predictive of efficacy. Longer cisternal nerve length (OR, 0.85; P = .005), prior radiofrequency ablation (OR, 0.35; P = .028), and diabetes mellitus (OR, 0.38; P = .013) predicted decreased efficacy. The mean dose delivered to the dorsal root entry zone dose in patients who developed facial numbness (57.6 Gy) was more than the mean dose (47.3 Gy) given to patients who did not develop numbness (P = .02).

CONCLUSION:

The development of post-GKRS facial numbness is a dominant factor that predicts for efficacy of GKRS. History of diabetes mellitus or previous radiofrequency ablation may portend worsened outcome.

PMID:
21849918
DOI:
10.1227/NEU.0b013e3182320d36
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center